WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.28 Cr | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.28 Cr |
| Mar2024 | ₹-0.57 Cr |
| Mar2023 | ₹-2.03 Cr |
| Mar2022 | ₹-2.04 Cr |
| Mar2021 | ₹0.68 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.28 Cr | Negative | |
| Mar2024 | ₹-0.57 Cr | Negative | |
| Mar2023 | ₹-2.03 Cr | Negative | |
| Mar2022 | ₹-2.04 Cr | Negative | |
| Mar2021 | ₹0.68 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,669.6 Cr | -2.6% | -7.4% | -14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -2.6% |
-7.4% |
-14.1% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses